0000000000593101

AUTHOR

Esther Ballester Asensio

showing 3 related works from this author

Medición objetiva y percepción subjetiva de los niveles de actividad física en una muestra de niños escolares

2015

El sedentarismo durante la infancia y adolescencia repercute directamente en los niveles de salud de la población. La actividad física se relaciona con una disminución del riesgo de obesidad e hígado graso y mejoría del perfil cardiometabólico en general, mayor masa ósea y fuerza muscular, e incremento en el desarrollo cognitivo a edades tempranas. Con este fin se ha recomendado la práctica de actividad física de intensidad moderada y/o vigorosa al menos durante 60 minutos diarios en niños mayores de 5 años, habiéndose desarrollado diversas guías para población infantil. Diferentes estudios demuestran unos niveles de sedentarismo altos siendo las niñas más sedentarias que los niños, y un cu…

sedentarismoescolaresacelerometríaUNESCO::CIENCIAS MÉDICASactividad físicacuestionario:CIENCIAS MÉDICAS [UNESCO]niños
researchProduct

Omalizumab outcomes for up to 6 years in pediatric patients with severe persistent allergic asthma

2021

BACKGROUND: Various studies have assessed omalizumab outcomes in the clinical practice setting but follow-up and/or number of patients included were limited. We aim to describe the long-term outcomes of pediatric patients with severe persistent allergic asthma receiving omalizumab in the largest real-life cohort reported to date. METHODS: ANCHORS was a multicenter, observational, retrospective cohort study conducted in 25 Pediatric Allergy and Pulmonology units in Spain. We collected data of patients < 18 years and initiating omalizumab between 2006 and 2018, from the year prior to omalizumab initiation to discontinuation or last available follow-up. The primary outcome was the evolution of…

severe asthmamedicine.medical_specialtyPediatricsImmunology*real lifeOmalizumabhumanized monoclonal antibodiesOmalizumab*adolescentsAntibodies Monoclonal HumanizedAnti-asthmatic Agent03 medical and health sciences0302 clinical medicinechildrenreal lifeInternal medicinemedicine*anti-asthmatic agents*childrenHumansImmunology and AllergyChildren adolescents anti-asthmatic agents humanized monoclonal antibodies observational study omalizumab real-life severe asthmaAnti-Asthmatic Agentsadolescents030212 general & internal medicineChildAdverse effectRetrospective Studiesbusiness.industryasthmatic agents*observational studyanti&#8208Retrospective cohort studyAsthmaDiscontinuation*omalizumabTreatment OutcomePulmonology030228 respiratory system*humanized monoclonal antibodies*severe asthmaSevere persistent allergic asthmaPediatrics Perinatology and Child HealthCohortomalizumabobservational studyObservational studybusinessmedicine.drugPediatric Allergy and Immunology
researchProduct

How bilastine is used to treat allergic rhinitis and urticaria in children

2021

Management guidelines for allergic rhinitis and urticaria recommend oral second-generation antihistamines as first-line treatment. The efficacy and safety of bilastine, the newest nonsedating second-generation antihistamine, are well established in adolescents/adults with these allergic conditions. The bilastine development program for pediatric use (2–&lt;12 years) followed EMA-authorized processes. Pharmacokinetic/pharmacodynamic simulation and modeling and a pharmacokinetic study were conducted to identify and confirm the pediatric dose (10 mg/day). A Phase III, multicenter, double-blind, randomized, placebo-controlled, parallel-group study was performed to confirm the safety of bilasti…

Histamine H1 Antagonists Non-Sedatingmedicine.medical_specialtyAdolescentUrticariaSecond Generation Antihistaminesmedicine.medical_treatmentImmunologychemistry.chemical_compoundDouble-Blind MethodPiperidinesPharmacokineticsHumansImmunology and AllergyMedicineRoutine clinical practiceChildBilastinebusiness.industryRhinitis AllergicDermatologyTreatment OutcomeOncologychemistryPharmacodynamicsBenzimidazolesAntihistaminebusinessImmunotherapy
researchProduct